Benzinga - by Lisa Levin, Benzinga Editor.
U.S. stocks traded mostly higher midway through trading, with the Dow Jones gaining around 100 points on Tuesday.
The Dow traded up 0.31% to 34,090.15 while the NASDAQ fell 0.05% to 13,560.52. The S&P 500 also rose, gaining, 0.25% to 4,384.43.
Check This Out: Accenture, Robinhood And 2 Other Stocks Insiders Are Selling
Leading and Lagging Sectors
Energy shares climbed by 1% on Tuesday.
In trading on Tuesday, information technology shares fell by 0.9%.
Top Headline
Goldman Sachs Group Inc (NYSE: GS) reported better-than-expected earnings for its third quarter on Tuesday.
The company posted quarterly earnings of $5.47 per share, down from $8.25 per share a year ago, beating the consensus of $5.31 per share. Net revenues were $11.82 billion, almost in line with Q3 FY22.
Equities Trading UP
SciSparc Ltd. (NASDAQ: SPRC) shares shot up 119% to $6.21. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.
Shares of Assembly Biosciences, Inc. (NASDAQ: ASMB) got a boost, shooting 93% to $1.40 after the company and Gilead announced they entered into a 12-year partnership to advance the research and development of novel antiviral therapies.
Olink Holding AB (NASDAQ: OLK) shares were also up, gaining 66% to $24.83 after Thermo Fisher Scientific announced it will acquire the company.
Equities Trading DOWN
Evelo Biosciences, Inc. (NASDAQ: EVLO) shares dropped 52% to $1.41. Evelo Biosciences released top-line results from its Phase 2 clinical study with EDP2939 in moderate psoriasis.
Shares of NetScout Systems, Inc. (NASDAQ: NTCT) were down 17% to $22.80 after the company reported weak preliminary results for the second quarter and lowered its FY24 guidance.
Monte Rosa Therapeutics, Inc. (NASDAQ: GLUE) was down, falling 20% to $4.02 as the company announced interim data from the Phase 1 dose escalation part of its ongoing phase 1/2 study of MRT-2359 in patients with MYC-driven solid tumors.
Also Check This Out: Top 4 Defensive Stocks Which Could Rescue Your Portfolio This Month
Commodities
In commodity news, oil traded up 0.6% to $87.14 while gold traded up 0.1% at $1,936.50.
Silver traded up 1.3% to $23.09 on Tuesday while copper rose 0.1% to $3.5870.
Euro zone
European shares were mostly lower today. The eurozone’s STOXX 600 fell 0.34%, London’s FTSE 100 rose 0.40% while Spain’s IBEX 35 Index fell 0.25% The German DAX fell 0.31% French CAC 40 fell 0.23%, while Italy’s FTSE MIB Index slipped 0.41%.
The ZEW Indicator of Economic Sentiment for the Eurozone rose to 2.3 in October from -8.9 in a month ago. The ZEW Indicator of Economic Sentiment for Germany climbed by 10.3 points to a reading of -1.1 in October.
Average weekly earnings, including bonuses in the UK, rose 8.1% year-over-year to GBP 661/week during the three months to August. UK’s number of job vacancies fell to 988,000 in the third quarter.
Asia Pacific Markets
Asian markets closed higher on Tuesday, with Japan’s Nikkei 225 gaining 1.20%, China’s Shanghai Composite Index gaining 0.32% and Hong Kong’s Hang Seng Index gaining 0.75%. India’s S&P BSE Sensex, meanwhile, rose 0.4%.
Total passenger vehicle sales in India climbed by 3.1% year-over-year to 316,908 in September. Singapore's non-oil domestic exports declined by 13.2% year-over-year in September following a revised 22.5% decline in August.
Economics
U.S. retail sales rose 0.7% month-over-month in September versus a revised 0.8% increase in August and topping estimates of a 0.3% increase.
U.S. industrial production rose 0.3% month-over-month in September, beating market expectations for a flat reading.
The NAHB/Wells Fargo Housing Market Index declined by 4 points to 40 in October, missing market estimates of 44.
Total business inventories rose by 0.4% month-over-month in August versus a revised 0.1% increase a month ago.
Now Read This: These 3 Materials Stocks Delivering High-Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.